NCT03734445 is a NA clinical trial of Vitamin Supplement in Diabetes Mellitus, Type 2, sponsored by Universidad Autonoma del Estado de Mexico.

Who is sponsoring NCT03734445?

NCT03734445 is sponsored by Universidad Autonoma del Estado de Mexico.

What drugs are being tested in NCT03734445?

Interventions in NCT03734445: Vitamin Supplement, Placebo.

What condition does NCT03734445 study?

NCT03734445 studies Diabetes Mellitus, Type 2.

Is NCT03734445 still recruiting?

NCT03734445 is currently status unknown. Last updated 1 October 2019.

Last reviewed 2019-10-01 · How we verify

NCT03734445

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Vitamin C, D and Zinc Supplementation on the Immune and Inflammatory Process in Type 2 Diabetic Subjects

Status unknown NA Last updated 1 October 2019

What this trial tests

NA trial testing Vitamin Supplement in Diabetes Mellitus, Type 2 in 120 participants. Status unknown.

Timeline

9 January 2020

Primary endpoint
9 January 2020

26 March 2020

Quick facts

Lead sponsor	Universidad Autonoma del Estado de Mexico
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	120
Start date	9 January 2020
Primary completion	9 January 2020
Estimated completion	26 March 2020

Drugs / interventions tested

Vitamin Supplement
Placebo

Conditions studied

Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →

Sponsor

Universidad Autonoma del Estado de Mexico

Who can join

Adults 25 to 55, any sex, with Diabetes Mellitus, Type 2. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Type 2 Diabetes Mellitus According to the World Health Organization (WHO), there are more than 346 million individuals with diabetes, of which 90% are type 2. Global estimations for the year 2030 predict an epidemic increase that will reach 366 million. According to the National Nutrition and Health Survey of 2006 (ENSANUT2005), there are 6.4 million type 2 diabetic subjects in Mexico. According to the calculation of the sample size, the investigators will include 120 adults with type 2 diabetes mellitus selected from the outpatient preventive medicine offices of health centres in the State of Mexico who will divided in two groups: supplement and placebo (60 per group). After having been invited to participate and obtaining the informed consent, study subjects will be evaluated for dietary information, as well as biochemical biomarkers of metabolic control, anthropometric, immune and inflammatory markers, gut microbiota and oxidative stress, before beginning the trial, and after 12 and 24 weeks of supplementation. They will have a monthly follow-up visit for evaluation of adherence and adverse effects, as well as delivery of the supplement.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Diabetes Mellitus, Type 2

Currently open trials in the same condition.

NCT07415954 — A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 · Phase 2 · recruiting
NCT07532863 — A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Part · recruiting
NCT07336329 — Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use · NA · recruiting
NCT07242469 — A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006) · Phase 1 · recruiting
NCT07444203 — Transformative Research in Diabetic Nephropathy 2.0 · recruiting

Other Universidad Autonoma del Estado de Mexico trials

Trials by the same sponsor.

NCT06993064 — Effect of Vitamin D on Inflammatory Markers in Type 2 Diabetes Mellitus in Mexico. · NA · not yet recruiting
NCT03700931 — Influence of Episodic Memory on Healthy Eating · NA · completed
NCT03653559 — Effect of Consuming "Home Meals" on Body Weight · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03734445 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidad Autonoma del Estado de Mexico
Last refreshed: 1 October 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03734445.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing